Swiss - Delayed Quote CHF
Newron Pharmaceuticals S.p.A. (NWRN.SW)
As of 5:07 PM GMT+2. Market Open.
Research Analysis
Revenue vs. Earnings
Revenue 1.7M
Earnings -4.78M
Analyst Price Targets
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | 3 | 3 |
Avg. Estimate | 0 | 0 | 0.04 | 0.07 |
Low Estimate | 0 | 0 | -0.89 | -0.91 |
High Estimate | 0 | 0 | 1.13 | 1.15 |
Year Ago EPS | -- | -- | -0.88 | 0.04 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | 3 | 3 |
Avg. Estimate | -- | -- | 21.71M | 22.74M |
Low Estimate | -- | -- | 7.07M | 7.14M |
High Estimate | -- | -- | 34.49M | 34.87M |
Year Ago Sales | -- | -- | 8.77M | 21.71M |
Sales Growth (year/est) | -- | -- | 147.40% | 4.70% |
Earnings History
CURRENCY IN USD | |
---|---|
EPS Est. | -- |
EPS Actual | -- |
Difference | -- |
Surprise % | -- |
EPS Trend
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0.04 | 0.07 |
7 Days Ago | 0 | 0 | 0.04 | 0.07 |
30 Days Ago | 0 | 0 | 0.04 | 0.07 |
60 Days Ago | 0 | 0 | 0.04 | 0.07 |
90 Days Ago | 0 | 0 | 0 | -0.02 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
CURRENCY IN USD | NWRN.SW | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -- | -- | -- | 3.60% |
Next Qtr. | -- | -- | -- | 7.90% |
Current Year | 104.50% | -- | -- | 2.50% |
Next Year | 75.00% | -- | -- | 13.10% |
Next 5 Years (per annum) | -- | -- | -- | 11.87% |
Past 5 Years (per annum) | -- | -- | -- | -- |
Related Tickers
IDIA.SW Idorsia Ltd
1.1940
+1.79%
MOLN.SW Molecular Partners AG
5.68
+27.64%
SANN.SW Santhera Pharmaceuticals Holding AG
8.95
-2.61%
RLF.SW Relief Therapeutics Holding SA
6.10
+15.53%
SPEX.SW Spexis AG
0.0570
0.00%
EVE.SW Evolva Holding SA
0.8120
-7.73%
ONWD.BR Onward Medical N.V.
6.10
+2.69%
LT4.F Liquidia Corporation
10.20
-2.11%
MEB.F MedinCell S.A.
15.80
+3.00%
HPHA.F Heidelberg Pharma AG
2.6100
-2.61%